Netherlands-based Amethyst Healthcare, a European cancer care provider, has established a presence in Portugal with the acquisition of private Portuguese radiotherapy provider Júlio Teixeira. The move adds to Amethyst’s expanding clinical network and increases the number of patients treated by the group each year by approximately 3,000.
Júlio Teixeira, founded in Porto in 1994, has clinics located in Porto, at the Instituto CUF, the leading private healthcare hub in northern Portugal, and radiotherapy department of Braga Hospital.
The move will enable further expansion in Portugal, with other potential acquisition targets under consideration in the main cities and the south of the country.
Founded in 2010 Amethyst, which was acquired by Fremman Capital from TRG in April, operates 21 centres across seven countries (France, Poland, Romania, UK, Italy, Austria, Portugal), equipped with 41 linear accelerators and treating around 50,000 patients annually. The group generates about 75% of revenues from radiotherapy, complemented by chemotherapy and diagnostic imaging.
The firm combines local medical teams with a centralised management structure to ensure consistent standards and capture operational synergies. It employs around 500 FTEs and approximately 100 doctors, and operates under reimbursement-based frameworks in close partnership with public health systems.
TRG invested in Amethyst in 2019.
Press release: Amethyst Healthcare Launches Portugal Presence
